Please use this identifier to cite or link to this item: http://bura.brunel.ac.uk/handle/2438/8926
Title: The fetal mouse is a sensitive genotoxicity model that exposes lentiviral-associated mutagenesis resulting in liver oncogenesis
Authors: Nowrouzi, A
Cheung, WT
Li, T
Zhang, X
Arens, A
Paruzynski, A
Waddington, SN
Osejindu, E
Reja, S
von Kalle, C
Wang, Y
Al-Allaf, F
Gregory, L
Themis, M
Holder, M
Dighe, N
Ruthe, A
Buckley, SM
Bigger, B
Montini, E
Thrasher, AJ
Andrews, R
Roberts, TP
Newbold, RF
Coutelle, C
Schmidt, M
Themis, M
Keywords: Gene therapy;Genotoxicity models;Retroviral vector biosafety;Lentiviral vectors
Issue Date: 2013
Publisher: Nature Publishing Group
Citation: Molecular Therapy, 21(2), 324 - 337, 2013
Abstract: Genotoxicity models are extremely important to assess retroviral vector biosafety before gene therapy. We have developed an in utero model that demonstrates that hepatocellular carcinoma (HCC) development is restricted to mice receiving nonprimate (np) lentiviral vectors (LV) and does not occur when a primate (p) LV is used regardless of woodchuck post-translation regulatory element (WPRE) mutations to prevent truncated X gene expression. Analysis of 839 npLV and 244 pLV integrations in the liver genomes of vector-treated mice revealed clear differences between vector insertions in gene dense regions and highly expressed genes, suggestive of vector preference for insertion or clonal outgrowth. In npLV-associated clonal tumors, 56% of insertions occurred in oncogenes or genes associated with oncogenesis or tumor suppression and surprisingly, most genes examined (11/12) had reduced expression as compared with control livers and tumors. Two examples of vector-inserted genes were the Park 7 oncogene and Uvrag tumor suppressor gene. Both these genes and their known interactive partners had differential expression profiles. Interactive partners were assigned to networks specific to liver disease and HCC via ingenuity pathway analysis. The fetal mouse model not only exposes the genotoxic potential of vectors intended for gene therapy but can also reveal genes associated with liver oncogenesis.
Description: This article is available open access through the publisher’s website at the link below. Copyright @ 2013 The American Society of Gene & Cell Therapy.
URI: http://www.nature.com/mt/journal/v21/n2/full/mt2012224a.html
http://bura.brunel.ac.uk/handle/2438/8926
DOI: http://dx.doi.org/10.1038/mt.2012.224
ISSN: 1525-0016
Appears in Collections:Biological Sciences
Dept of Life Sciences Research Papers

Files in This Item:
File Description SizeFormat 
Notice.pdf43.98 kBAdobe PDFView/Open


Items in BURA are protected by copyright, with all rights reserved, unless otherwise indicated.